Summary of evidence on blood glucose management in diabetes patients with acute coronary syndrome
10.3760/cma.j.cn115682-20240407-01858
- VernacularTitle:糖尿病合并急性冠脉综合征患者血糖管理的证据总结
- Author:
Di XU
1
;
Jinling DING
1
;
Qianqian SUN
1
;
Wei DAI
1
Author Information
1. 南京大学医学院附属鼓楼医院心血管内科，南京 210008
- Publication Type:Journal Article
- Keywords:
Diabetes;
Acute coronary syndrome;
Blood glucose management;
Best evidence;
Evidence-based nursing
- From:
Chinese Journal of Modern Nursing
2024;30(35):4828-4834
- CountryChina
- Language:Chinese
-
Abstract:
Objective:Diabetes is closely linked to acute coronary syndrome (ACS) and serves as a risk factor for ischemic heart disease. It is crucial to optimize blood glucose monitoring and management in ACS patients to improve quality of life and reduce mortality. However, current guidelines and standards are fragmented and lack a cohesive approach to blood glucose monitoring and management in this population. This study aims to review and analyze evidence regarding blood glucose monitoring and management in diabetes patients post-ACS and provide theoretical support for clinical practice.Methods:Following the "6S" evidence model, a systematic search was conducted across multiple databases and various diabetes association websites. The search included clinical decisions, recommended practices, guidelines, systematic reviews, expert consensus, and evidence summaries related to blood glucose monitoring and management in diabetes patients with ACS. The search timeframe was from database inception to February 29, 2024. Two evidence-trained researchers independently assessed the quality and extracted data, with a third reviewer consulted for discrepancies.Results:A total of 16 documents were included, including one clinical decision document, two Meta-analyses, four expert consensus documents, eight guidelines, and one systematic review. Six dimensions emerged from the evidence: blood glucose monitoring and management, glucose control targets, pharmacologic and non-pharmacologic interventions, hypoglycemia prevention and treatment, team-based training, and discharge planning.Conclusions:Clinical application should prioritize personalized, diversified approaches to blood glucose management and balance target values with patient safety. Hypoglycemia prevention and consistent monitoring are essential to avoid adverse events. Patient preferences and individual conditions should guide evidence feasibility and applicability assessments, thereby enabling the development of tailored blood glucose management plans that can effectively lower blood glucose levels and improve outcomes.
